Opportunities and challenges for the development of antisense treatment in neuromuscular disorders.
about
Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophyUpregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis.
P2860
Opportunities and challenges for the development of antisense treatment in neuromuscular disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Opportunities and challenges f ...... nt in neuromuscular disorders.
@en
Opportunities and challenges f ...... nt in neuromuscular disorders.
@nl
type
label
Opportunities and challenges f ...... nt in neuromuscular disorders.
@en
Opportunities and challenges f ...... nt in neuromuscular disorders.
@nl
prefLabel
Opportunities and challenges f ...... nt in neuromuscular disorders.
@en
Opportunities and challenges f ...... nt in neuromuscular disorders.
@nl
P2860
P1476
Opportunities and challenges f ...... nt in neuromuscular disorders.
@en
P2093
Maaike van Putten
P2860
P304
P356
10.1517/14712598.2011.579098
P407
P577
2011-04-22T00:00:00Z